FMC

FMC Investors - Our Quick Report For You.

Large-cap Basic Materials company FMC has moved -1.5% so far today on a volume of 314,546, compared to its average of 802,693. In contrast, the S&P 500 index moved 0.4%.

FMC trades -8.13% away from its average analyst target price of $141 per share. The 17 analysts following the stock have set target prices ranging from $112 to $152, and on average have given FMC a rating of buy.

Anyone interested in buying FMC should be aware of the facts below:

  • FMC's current price is 155.6% above its Graham number of $50.68, which implies that at its current valuation it does not offer a margin of safety

  • FMC has moved 15.9% over the last year, and the S&P 500 logged a change of -14.8%

  • Based on its trailing earnings per share of 5.73, FMC has a trailing 12 month Price to Earnings (P/E) ratio of 22.6 while the S&P 500 average is 15.97

  • FMC has a forward P/E ratio of 15.5 based on its forward 12 month price to earnings (EPS) of $8.38 per share

  • The company has a price to earnings growth (PEG) ratio of 1.96 — a number near or below 1 signifying that FMC is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 5.1 compared to its sector average of 1.86

  • FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products.

  • Based in Philadelphia, the company has 6,400 full time employees and a market cap of $16,317,634,560. FMC currently returns an annual dividend yield of 1.6%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS